Coronavirus Offers Opportunities and Challenges

In this ISSUE

Overcoming Transportation Barriers to Trial Participation

Unleashing New Insights from Toxicology Studies

Can Recruitment and Retention Get Any Worse?

Blog

Coronavirus Offers Opportunities and Challenges for Biopharma R&D

The research community is moving quickly to launch clinical trials of potential countermeasures, while regulatory authorities aim to support product development through regulatory flexibility.
... /Read more/

Three Key Critical Considerations Before Embarking on Decentralized Trials
Tuesday, January 28, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET
On Demand

Q&A

AI and Machine Learning in Diagnosing Clinical Trial Patients

John Rigg, Senior Principal, Predictive Analytics, Real World Solutions at IQVIA, discusses how patient disease modeling and diagnostic prediction is made possible with artificial intelligence and machine learning.
... /Read more/

The Current and Future Impact of Artificial Intelligence (AI) on Pharmacovigilance
Tuesday, February 11, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET
On Demand

Clinical Operations

Assessing Suicide Risk in Clinical Trials: The Patient Knows Best

During clinical trials of pharmaceutical treatments, sponsors and CROs need to detect possible suicidal ideation and behavior related to their drug during baseline assessments, throughout treatment, as well as during the follow up phases.
... /Read more/

Industry News